Perceptive Advisors's book
32 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | $2.2B | — | — | |
| Imperative Care | Surgical Devices | $1.6B | — | — | |
| Talkiatry | — | $1.4B | — | — | |
| Twin Health | — | $950.0M | — | — | |
| Kardigan | Drug Discovery | $646.0M | — | — | |
| Galvanize Therapeutics | Therapeutic Devices | $300.0M | — | — | |
| Mythic Therapeutics | Drug Discovery | $293.0M | — | — | |
| Marea | — | $272.0M | — | — | |
| Neuron23 | — | $271.5M | — | — | |
| Crystalys Therapeutics | — | $263.0M | — | — | |
| + 22 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 32 recorded positions
- ·Watchlist + alerts for Perceptive Advisors's activity
Create free account
No card required